Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
暂无分享,去创建一个
C. Sweep | C. Meisner | N. Harbeck | M. Untch | F. Jänicke | C. Thomssen | M. Schmitt | H. Graeff | M. Schmitt | H. Selbmann | A. Prechtl | Anita Prechtl | Christoph Thomssen | Christoph Meisner | Michael Untch | Hans-Konrad Selbmann | M. Schmitt